The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Attorney General Nessel Urges Local Governments to Sign Up for $720 Million National Settlement from Eight Opioid Drug Makers Before October 8
September 24, 2025
LANSING – Michigan Attorney General Dana Nessel is urging eligible municipalities to participate in nationwide opioid settlements with eight drug makers before the October 8 deadline. By participating, eligible local governments will receive direct payments from the settlement, part of a nationwide $720 million agreement resolving litigation against the manufacturers for their role in the opioid crisis. Michigan governments stand to receive up to $24.5 million.
“These national settlements have already made a significant difference in the fight against the opioid epidemic,” Nessel said. “I hope that every eligible community signs on so we can maximize the resources available to save lives and support recovery across Michigan.”
The settlements from Mylan (now part of Viatris), Hikma, Amneal, Apotex, Indivior, Sun, Alvogen, and Zydus, allow 279 local units of government in Michigan – called subdivisions in the settlement agreement – to participate. The Department of Attorney General has a full list of eligible subdivisions on its website. Those subdivisions that need assistance with their participation forms may email the Department for additional instructions before the October 8 deadline.
Since taking office in 2019, Attorney General Nessel has focused intently on combatting the opioid epidemic and holding accountable those responsible for creating and fueling the crisis, resulting in more than $1.8 billion to Michigan governments through settlements with McKinsey & Co, Distributors (Cardinal Health, McKesson, Inc., and AmerisourceBergen), Janssen Pharmaceuticals, Teva Pharmaceuticals, Allergan Pharmaceutical, CVS, Walmart, and Walgreens. The money is distributed to the state and local units of government for opioid-use disorder treatment and remediation.
Analysis of provisional data from the Michigan Department of Health and Human Services (MDHHS) indicates a 34% reduction in overdose deaths between 2023 and 2024 – about 1,000 fewer deaths. This continued progress reflects the impact of sustained, strategic investment in prevention, treatment, recovery, and harm-reduction efforts – many of which are made possible through additional funding received as a result of Michigan’s participation in the national opioid settlements.
###
Media Contact: